Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.34B | 2.23B | 1.84B | 1.97B | 1.97B |
Gross Profit | 663.23M | 1.48B | 1.10B | 1.51B | 1.01B |
EBITDA | -861.91M | -253.39M | -1.46B | -437.63M | -60.13M |
Net Income | -1.73B | -758.25M | -1.83B | -745.43M | -1.16B |
Balance Sheet | |||||
Total Assets | 6.96B | 7.87B | 7.97B | 9.44B | 5.85B |
Cash, Cash Equivalents and Short-Term Investments | 1.72B | 2.24B | 2.66B | 4.46B | 2.05B |
Total Debt | 2.50B | 3.10B | 1.97B | 1.15B | 2.46B |
Total Liabilities | 5.15B | 5.07B | 5.73B | 5.22B | 4.60B |
Stockholders Equity | 1.73B | 2.70B | 2.15B | 4.06B | 1.05B |
Cash Flow | |||||
Free Cash Flow | -456.90M | -895.64M | -767.70M | -721.58M | -62.04M |
Operating Cash Flow | -332.22M | -595.70M | -729.89M | -675.19M | -47.91M |
Investing Cash Flow | 48.03M | -288.58M | -1.48B | -1.23B | -106.78M |
Financing Cash Flow | -171.99M | 821.71M | 66.75M | 3.94B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $33.22B | 5.99 | -11.76% | 1.91% | 5.54% | -19.87% | |
46 Neutral | HK$6.52B | ― | -77.88% | ― | -41.17% | -103.00% | |
$392.93M | ― | -16.87% | ― | ― | ― | ||
€896.61M | 12.32 | 8.12% | 4.59% | ― | ― | ||
65 Neutral | HK$2.66B | 72.20 | 3.79% | ― | 17.66% | 97.73% | |
47 Neutral | HK$5.20B | ― | -3.94% | 3.60% | -14.05% | 68.56% | |
46 Neutral | HK$2.78B | ― | -36.81% | ― | -14.38% | -56.66% |
Weimob Inc. successfully held its Annual General Meeting on May 16, 2025, where all proposed resolutions were passed by shareholders. Key decisions included the re-election of directors, re-appointment of PricewaterhouseCoopers as auditors, and granting mandates to the board for share issuance and repurchase. These resolutions reflect Weimob’s commitment to maintaining strong governance and strategic flexibility, potentially bolstering its market position and shareholder confidence.
The most recent analyst rating on (HK:2013) stock is a Sell with a HK$1.55 price target. To see the full list of analyst forecasts on Weimob stock, see the HK:2013 Stock Forecast page.
Weimob Inc. has announced its annual general meeting scheduled for May 16, 2025, in Shanghai, where shareholders will discuss various resolutions. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of PricewaterhouseCoopers as the auditor, and authorization for the board to manage share allotments. These decisions are pivotal for Weimob’s governance and operational strategies, potentially impacting shareholder value and the company’s market positioning.